When Does Kidney Disease Need Dialysis or Transplant Planning? What Stage-Based Care Means

Key Takeaways
- Dialysis is usually started at stage 5 kidney disease, when eGFR falls below 15 and symptoms or blood changes appear, not simply when the number is crossed.
- The IDEAL randomized trial found no survival benefit from starting dialysis at an eGFR of 10 to 14 compared with waiting for symptoms or a lower reading.
- Transplant evaluation commonly begins at stage 4, often when eGFR drops below about 20, because the workup takes months and a preemptive transplant avoids dialysis altogether.
- An arteriovenous fistula typically needs two to three months to mature before use, which is why access surgery is planned well before dialysis is needed.
- Standard in-center hemodialysis runs about three sessions a week of roughly four hours each, while peritoneal dialysis is done daily at home through an abdominal catheter.
- Conservative kidney management is a recognized third option that treats symptoms without dialysis and may suit people with significant frailty or other serious illness.
Kidney disease usually needs dialysis when the kidneys have lost most of their filtering ability, typically an eGFR below 15 (stage 5), and symptoms such as fluid overload, rising potassium, persistent nausea or confusion appear despite medical management. Transplant planning normally starts earlier, often around stage 4, so a living-donor or waiting-list option exists before dialysis becomes necessary. Timing is individual and decided with the kidney team.
The nephrology appointment ends with a sentence that sounds oddly administrative: “We should start talking about your options.” The lab number on the screen, an eGFR in the twenties, has not changed much since last visit. You feel tired, but you have felt tired for years. Nobody said the word emergency. Yet the conversation has shifted from protecting your kidneys to planning for the day they can no longer do the job on their own.
That gap between feeling mostly fine and being told to prepare is where most confusion about kidney failure lives. People picture dialysis as something that begins the moment a number crosses a line. In practice, the question of when kidney disease needs dialysis has two parts: how much function is left, and how the body is coping with what is left. Transplant planning follows a different, earlier clock.
This explainer walks through both, stage by stage, using what guideline bodies and large trials actually show rather than what the waiting room rumor mill suggests.
When does kidney disease need dialysis? The short, honest version
Dialysis is a treatment that takes over part of the kidneys’ job of removing waste products, extra salt and extra water from the blood. It does not repair kidneys; it substitutes for them. So the real question is not “when are my kidneys damaged?” but “when can my body no longer manage without that substitution?”
Two things are weighed together. The first is the estimated glomerular filtration rate, or eGFR, a blood-test calculation that estimates how many milliliters of blood the kidneys filter each minute. The NHS describes dialysis as usually needed once the kidneys have lost around 85 to 90 percent of their function, which corresponds to the lowest stage of chronic kidney disease. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) puts it similarly: dialysis is generally considered when function falls to about 15 percent or less.
The second factor is the body’s response. Some people with an eGFR of 12 walk into clinic working full time. Others at the same number are breathless from fluid in the lungs, cannot keep food down, or have potassium levels that threaten heart rhythm. Guideline practice, reflected across the NHS, Mayo Clinic and NIDDK, is to start dialysis when symptoms or dangerous blood chemistry appear, not simply when a threshold is crossed.
That is why two people with identical lab results can be given different advice. One is asked to start within weeks. The other is monitored monthly and told to keep preparing. Neither is being treated carelessly; both are being treated according to what their body is actually doing.
The honest summary: most people begin dialysis at stage 5, when eGFR is below 15, and the trigger is usually a combination of that number plus symptoms or blood changes that medicines and diet can no longer control.
What stage of kidney disease requires dialysis? The five stages explained
Chronic kidney disease (CKD) is a long-term condition in which kidney function is reduced or kidneys are structurally damaged for three months or more. Clinicians divide it into stages based mainly on eGFR, with stage 3 split into two halves because the risks differ.

| Stage | eGFR (mL/min/1.73m²) | What it usually means | Typical focus of care |
|---|---|---|---|
| 1 | 90 or higher | Normal filtering, but signs of damage such as protein in urine | Treat the cause, protect blood pressure and blood sugar |
| 2 | 60–89 | Mildly reduced function with evidence of damage | Same as stage 1, plus regular monitoring |
| 3a | 45–59 | Mild to moderate reduction | Slow progression, check for anemia and bone changes |
| 3b | 30–44 | Moderate to severe reduction | Closer monitoring, often specialist referral |
| 4 | 15–29 | Severe reduction | Education about dialysis and transplant, access planning |
| 5 | Below 15 | Kidney failure | Dialysis, transplant, or conservative management |
The pattern that matters for planning: dialysis itself belongs to stage 5, but the preparation that makes dialysis safe or transplant possible belongs to stage 4. The Mayo Clinic and NHS both describe stage 4 as the point where kidney teams begin structured conversations about replacement therapy, because arranging a surgical access point or completing a transplant evaluation takes months.
Stage numbers also do not move in a straight line for everyone. Some people sit at stage 3b for a decade. Others, particularly with uncontrolled diabetes or certain inherited conditions, move through stage 4 within a couple of years. Your team tracks the slope, not just the current reading, which is why they often plot eGFR over time rather than reacting to a single result.
When is dialysis needed by eGFR, and what the number cannot tell you
eGFR is an estimate, not a direct measurement. It is calculated from the blood level of creatinine, a waste product from muscle, adjusted for age and sex. Because muscle mass affects creatinine, a very muscular person may have a lower eGFR than their true function, and someone with low muscle mass may appear better than they are. Mayo Clinic notes that the calculation can also be thrown off by dehydration, a recent large meat meal, or certain medicines.
This is one reason kidney teams rarely act on one value. A single eGFR of 14 after a week of vomiting from a stomach virus may rebound to 19 once fluids are restored. Guidelines therefore ask for repeat testing before labeling someone as being at stage 5, and before dialysis is considered on the basis of numbers alone.
What the number also cannot show is how the rest of the body is coping. Clinicians look at a cluster of markers alongside eGFR:
- Potassium, because high levels can disturb heart rhythm
- Bicarbonate, because acid builds up when kidneys fail
- Hemoglobin, since the kidneys make a hormone that drives red blood cell production
- Phosphate and calcium, which affect bones and blood vessels
- Weight and blood pressure trends that signal fluid retention
Symptoms are read in the same way. Loss of appetite, a metallic taste, itching, cramps at night, swollen ankles and difficulty concentrating are the classic features of uremia, the state in which waste products accumulate to toxic levels. When these appear and do not respond to medicines, diet and fluid adjustments, the balance tips toward starting dialysis even if eGFR is hovering just above 15.
In short, eGFR tells the team where you are on the map. The blood chemistry and how you feel tell them how fast the ground is shifting beneath you.
How dialysis works: what actually happens to your blood
Healthy kidneys filter roughly the body’s entire blood volume many times a day, pulling out urea, excess potassium, acid and water while keeping proteins and cells. Dialysis copies the principle using a semi-permeable membrane, a thin barrier with pores small enough to let waste through but too small for blood cells.

In hemodialysis, blood is drawn from the body through a surgically created access point, pumped through a filter called a dialyzer, and returned. Inside the dialyzer, blood flows on one side of thousands of hollow fibers while a cleaning fluid called dialysate flows on the other. Waste moves from blood into dialysate because it is more concentrated in the blood, a process called diffusion. Extra water is removed by applying gentle pressure, called ultrafiltration. The NHS describes a typical schedule as three sessions a week, each lasting around four hours, although home programs may use shorter, more frequent sessions.
Peritoneal dialysis uses a membrane you already own: the peritoneum, the lining of the abdominal cavity. A soft tube is placed through the abdominal wall. Dialysate is run in, dwells for several hours while waste crosses into it, and is drained out. This is repeated through the day or overnight by a machine. Because it happens continuously, fluid and chemistry shifts are gentler than in a four-hour hemodialysis session.
Neither method does everything a kidney does. Dialysis does not make erythropoietin, the hormone that drives red blood cell production, nor does it activate vitamin D. Those jobs are covered by medicines prescribed alongside dialysis. Nor does it run around the clock the way kidneys do, which is why fluid and dietary limits remain part of life on treatment.
Understanding this mechanism helps explain the fatigue many people describe after a session: several liters of fluid and a day’s worth of waste are shifted in hours, and the body notices.
Hemodialysis vs peritoneal dialysis: the differences that shape daily life
The two main types of dialysis clear waste equally well for most people; the choice is less about biology than about how you want your week to look, what your body allows, and what support you have at home.
In-center hemodialysis means traveling to a unit on a fixed schedule, typically three times weekly, where nurses manage the machine. Between sessions you are free of equipment, but the schedule is rigid and the days after a two-day gap can bring more fluid build-up. NIDDK notes that home hemodialysis, where a trained partner or the patient runs the machine, allows more frequent sessions and more flexible timing.
Peritoneal dialysis puts you in charge. Exchanges are done at home, at work or while traveling, with a monthly clinic review. The trade-offs are a permanent abdominal catheter, storage space for supplies, a daily commitment with no days off, and a risk of peritonitis, an infection of the abdominal lining, if sterile technique slips. Some people are not suitable because of previous abdominal surgery, hernias or limited manual dexterity.
Clinicians also consider heart function (large fluid shifts in hemodialysis stress a weak heart), the condition of the arm veins, and how much remaining kidney function a person has, since peritoneal dialysis tends to preserve residual function somewhat longer.
The NHS and NIDDK both stress that this is a shared decision, and that people may switch methods as circumstances change. Someone starting on peritoneal dialysis may move to hemodialysis after years if the peritoneum becomes less effective. Someone who begins in-center may train for home treatment later. The first choice is rarely the last.
What matters most, in my reading of the evidence, is that the decision is made before an emergency forces it. People who start dialysis in an unplanned way via a neck catheter have far less say in which method they end up on.
Who dialysis is usually for, and who is usually asked to wait
Dialysis is usually recommended for people at stage 5 who have symptoms of uremia, fluid overload that medicines cannot control, dangerously high potassium or acid levels, or a steadily falling eGFR with nutritional decline. In those situations, waiting carries clear risk: pulmonary edema, heart rhythm problems and severe malnutrition.
Who is asked to wait? Often, people whose eGFR is between 10 and 15 but who feel well, eat normally, have stable weight and acceptable blood chemistry. The instinct is that earlier must be safer. The evidence says otherwise. The IDEAL trial, a randomized study of more than 800 adults published in the New England Journal of Medicine, compared starting dialysis at an eGFR of roughly 10 to 14 against waiting until 5 to 7 or until symptoms appeared. There was no difference in survival or in major complications between the groups. Many in the “late” group started earlier than planned because symptoms arrived, which is exactly how clinic practice works.
Waiting is not neglect. It is active monitoring, usually with blood tests every few weeks, continued blood pressure and fluid management, dietary support, and a completed access or transplant plan ready to go. The aim is to spare people months of treatment they do not yet need, since each hour on dialysis has costs in time, energy and risk of access complications.
There are also people for whom dialysis is medically possible but may not be the right choice. Those with advanced frailty, severe dementia or other life-limiting illness may not gain the benefit younger or fitter patients do, and the burden of thrice-weekly sessions may outweigh it. For them, conservative kidney management, discussed later, is an actively offered path, not a default.
The decision of when to start remains with the treating nephrologist, informed by labs, symptoms and the person’s own priorities.
Kidney transplant vs dialysis: why planning starts earlier than most people expect
A kidney transplant is an operation placing a donated kidney into the lower abdomen, connecting it to blood vessels and the bladder, while the original kidneys are usually left in place. For medically suitable people, NIDDK and the NHS describe it as the treatment that most closely restores normal kidney function and offers greater freedom than dialysis. It is not a procedure of last resort after years of treatment; ideally it is planned before dialysis begins.
This is where timing surprises families. Transplant evaluation is a thorough process: heart tests, cancer screening, infection checks, dental review, imaging of blood vessels and a psychosocial assessment. It commonly takes months to complete. Many programs begin referral when eGFR falls below about 20, well inside stage 4, precisely so the workup finishes before kidney failure arrives.
There are two sources of kidneys. A living donor, often a relative, partner or friend, can be assessed in parallel, and if compatible the transplant can be scheduled before dialysis is ever needed. This is called a preemptive transplant. A deceased-donor kidney requires joining a waiting list; NIDDK notes that waiting times are often measured in years and vary by blood group and region.
Transplant is not for everyone. Active cancer, uncontrolled infection, severe heart or lung disease, and conditions that would make lifelong immunosuppressant medicines unsafe may rule it out or delay it. Immunosuppressants are drugs that dampen the immune system so it does not attack the new kidney; they must be taken for as long as the kidney works, and they raise infection and some cancer risks.
Compared with dialysis, a working transplant means no sessions, fewer dietary limits and, for suitable candidates, better long-term outcomes in guideline summaries. Against that sit surgical risk, lifelong medicines and the possibility the kidney eventually fails. Weighing these is the team’s job together with you, and it should begin at stage 4, not stage 5.
Stage 4 kidney disease: what to expect from a planning visit
Stage 4, with eGFR between 15 and 29, is the stage of preparation. If you have recently been told you are here, the appointments change character. Fewer minutes are spent on slowing decline, although that continues, and more on education and logistics.
A typical pathway, described across NHS and NIDDK patient material, includes:
- A structured education session, often with a specialist nurse, covering hemodialysis, peritoneal dialysis, transplant and conservative management
- Dietitian review, since protein, potassium, phosphate and salt intake may need adjusting as function falls
- Anemia management, because the kidneys’ hormone output for red blood cells drops
- Vaccination review, particularly hepatitis B for anyone likely to start hemodialysis
- Vein protection advice for one arm, so it remains available for a future access
- Transplant referral when criteria are met
Blood tests move to roughly every one to three months depending on the pace of change. You may be asked to monitor home blood pressure and weight, since a rapid rise in weight often signals fluid rather than fat.
Medicines may be reviewed. Some drugs that protect the kidneys at earlier stages are continued; others, including certain painkillers and some diabetes medicines, are adjusted or stopped because they are cleared by the kidneys or can harm them. The NHS advises against taking over-the-counter anti-inflammatory painkillers without checking, because they can accelerate decline. Any change should come from the prescribing clinician, never from the pharmacy aisle on your own.
Emotionally, stage 4 is often harder than stage 5. The future is being planned while the present feels manageable, and that mismatch can read as premature. It is worth naming that feeling to your team. Kidney units routinely offer counseling or peer support, and families frequently say the hardest visit was the one where plans were first laid out, not the one where treatment started.
Preparing dialysis access: fistulas, grafts, catheters and realistic timelines
Hemodialysis needs a reliable way to move blood out and back at high flow, far more than an ordinary vein can tolerate. Creating that access is the single most time-sensitive step in stage 4 planning, and it is why “start talking now” is not alarmism.
The preferred option is an arteriovenous fistula: a surgeon joins an artery directly to a vein, usually in the forearm or upper arm, under local or regional anesthesia. The high-pressure arterial flow makes the vein enlarge and thicken over the following weeks. NIDDK states that a fistula typically needs two to three months to mature before it can be used, and some take longer or fail to develop, requiring a second attempt. Fistulas last longer and carry the lowest infection risk of any access, which is why guidelines favor them.
If veins are too small or fragile, an arteriovenous graft uses a synthetic tube to connect artery and vein. Grafts can be used within weeks but are more prone to clotting and infection than fistulas.
When dialysis is needed before either is ready, a central venous catheter is placed into a large vein in the neck or chest. It works immediately but carries the highest infection and clotting risk, and prolonged use can narrow central veins. Guidelines treat catheters as a bridge, not a destination.
Peritoneal dialysis access is simpler: a catheter is placed into the abdomen, usually under general or local anesthesia, and most programs allow it to heal for around two weeks before regular use.
Practical consequences follow. Once an arm is earmarked for a fistula, blood draws and blood pressure cuffs should move to the other arm. After surgery, you will be taught to feel for the “thrill,” a buzzing vibration that confirms flow, and to report any loss of it promptly. Decisions about which access and when are made by the surgical and nephrology team together.
What the first weeks on dialysis usually look like
Starting dialysis is less a single event than an adjustment period measured in weeks. The body has been living with accumulated waste for months; removing it too quickly can cause headache, cramps and nausea, so most units begin gently.
In hemodialysis, early sessions are often shorter than the standard, building up to the full duration over the first one to two weeks as the team learns how much fluid you can tolerate losing and how your blood pressure behaves. A “dry weight,” the target weight when excess fluid has been removed, is estimated and then refined session by session. Expect frequent blood tests and dose adjustments to anemia and bone medicines during this phase.
Common experiences in the first month, described by NIDDK and MedlinePlus patient material, include tiredness for several hours after sessions, muscle cramps toward the end of treatment, light-headedness when standing, and a shift in appetite as uremic symptoms clear. Many people report that nausea and the metallic taste improve within weeks, which is one of the earliest noticeable benefits.
Peritoneal dialysis begins with training, typically one to two weeks of daily sessions where you or a family member learns sterile exchange technique, catheter care and how to recognize cloudy fluid, the early sign of peritonitis. Exchanges then begin at home with phone support and an early clinic review.
Diet and fluid rules usually become more specific now. A dietitian will set a daily fluid allowance based on urine output and set potassium and phosphate targets. These are not fixed forever; people who keep some urine output often have more room.
Work, driving and travel are usually possible, though schedules need rearranging. The practical advice from kidney units is to treat the first six to eight weeks as a settling-in period rather than judging how life on dialysis will feel from the first few sessions.
Conservative kidney management: the option few people hear about early enough
Not everyone with kidney failure chooses dialysis, and not everyone is better off with it. Conservative kidney management, sometimes called supportive or non-dialytic care, is a planned approach that treats the symptoms and complications of kidney failure with medicines, diet and close follow-up, without dialysis. The NHS lists it as a formal treatment option alongside dialysis and transplant.
It is most often chosen by people who are older or living with significant frailty, advanced heart failure, dementia or other serious illness, where the demands of dialysis may erode the quality of the time remaining without adding much to its length. Research summarized by kidney organizations suggests that for some very elderly people with multiple conditions, survival on dialysis and on conservative care can be similar, while hospital days are often fewer with conservative care. The evidence is observational rather than from randomized trials, so clinicians present it as a reasonable choice, not a guaranteed equivalent.
Conservative management is not the absence of treatment. It includes:
- Medicines for fluid balance, potassium, acid levels and anemia
- Treatment of itching, nausea, breathlessness and sleep disturbance
- Dietary adjustments to limit symptoms
- Advance care planning, so wishes are recorded while the person can state them
- Palliative care input when needed, focused on comfort
People on this pathway may live months or several years, depending on how quickly function declines and on their other conditions. The decision can also be revisited; some people begin conservative care and later choose a trial of dialysis, or the reverse.
Why raise it here? Because the question of when kidney disease needs dialysis has a sibling question that is often skipped: whether this person will benefit from dialysis at all. Guideline bodies increasingly expect kidney teams to present all three options honestly at stage 4, and families are entitled to ask for that conversation.
What people often get wrong about dialysis and transplant timing
Myths about kidney failure travel fast, partly because the disease is common and partly because it is quiet until late. A few deserve direct correction.
“Starting dialysis early buys time.” The IDEAL trial found no survival or complication advantage from starting at an eGFR of 10 to 14 compared with waiting for symptoms or a lower number. Earlier starts mostly add months of treatment burden. Planning early is wise; starting early, on its own, is not.
“Once you start dialysis, you can’t get a transplant.” The opposite is standard practice. Most transplants are performed in people already on dialysis. Being on treatment does not remove you from the list, though a preemptive transplant, where possible, is preferred.
“A transplant means no more medicines.” Immunosuppressants are lifelong and non-negotiable; stopping them risks rejection. Blood pressure and other medicines usually continue too.
“Dialysis fixes the kidneys.” It replaces part of their function. In chronic kidney disease the underlying kidneys do not recover; in acute kidney injury, which is a different condition, dialysis can be temporary while kidneys heal.
“Donating a kidney leaves the donor sick.” Living donors are screened intensively and generally live normal lives with one kidney, though they need lifelong blood pressure and kidney checks and carry a small long-term increase in risk that the transplant team explains in detail.
“Stage 3 means dialysis is around the corner.” Stage 3 is the most common stage, and most people in it never reach kidney failure. The main risk at stage 3 is cardiovascular disease, which is why blood pressure and cholesterol control dominate care there.
“If I feel fine, the number must be wrong.” Uremic symptoms often appear only below an eGFR of 15. Feeling well at stage 4 is normal, and it is exactly the window in which preparation is most useful.
Questions to ask your care team at stage 4 and stage 5
Kidney clinics are busy, and the most useful consultations are the ones where the patient arrives with specific questions. These are the ones nephrology nurses and physicians say they most want to be asked.
- How fast has my eGFR been falling over the past year, and what does that slope suggest about timing?
- Which symptoms or blood results would make you recommend starting dialysis, and which would you watch and wait through?
- Am I a candidate for a transplant evaluation now? If not, what would need to change?
- Is anyone in my family or circle able to be assessed as a living donor, and how does that process work?
- Which type of dialysis fits my heart, my veins, my home situation and my work, and can I switch later?
- If I need hemodialysis, when should the access surgery happen so a fistula has time to mature?
- Which arm should I protect from blood draws and blood pressure cuffs from now on?
- Which of my current medicines will change as function falls, and which over-the-counter products should I avoid?
- Would conservative kidney management be a reasonable choice for someone in my situation, and what would it involve?
- What vaccinations should I complete before starting treatment?
- Who do I call if I become breathless or confused at night or over a weekend?
- Is there a peer support program or counselor attached to the unit?
Write answers down or bring someone to take notes; most people retain only part of a dense consultation. Ask for the written information the unit uses and for a summary letter after key decisions.
One question worth asking yourself rather than the team: what matters most to you in the years ahead, whether that is independence, travel, time with family, or avoiding hospital stays? Kidney replacement decisions are among the few in medicine where that answer legitimately changes the clinical recommendation, and teams need to hear it.
When to call your doctor: red-flag signs at every stage
Most of kidney care is slow and scheduled. A small number of situations are not, and recognizing them can prevent a hospital emergency. The signs below apply whether you are being monitored at stage 4, waiting to start dialysis, already on treatment, or living with a transplant.
Seek urgent care or emergency services for:
- Breathlessness at rest, when lying flat, or waking you at night, which can signal fluid in the lungs
- Chest pain, a racing or irregular heartbeat, or new muscle weakness, which may reflect dangerously high potassium
- Confusion, unusual drowsiness, seizures or inability to stay awake
- Passing almost no urine for a day when you previously did
- For peritoneal dialysis: cloudy drained fluid, abdominal pain or fever
- For hemodialysis access: loss of the buzzing thrill, redness, pus, bleeding that does not stop with pressure, or a cold, painful hand
- For transplant recipients: fever, pain over the kidney, a sudden drop in urine, or inability to keep immunosuppressant medicines down because of vomiting
Call your kidney team promptly, within a day, for: persistent nausea or vomiting, a rapid weight gain of a few pounds over several days with swelling, severe itching or cramps, unexplained bruising or bleeding, a new infection, or any illness that stops you eating and drinking normally. Dehydration from vomiting or diarrhea can push a stage 4 kidney into temporary failure, and some medicines may need to be paused during such an illness, a decision for the prescriber.
Also contact the team before taking any new medicine, including herbal products and over-the-counter painkillers, since several are cleared by the kidneys or can damage them.
If you are unsure whether something is urgent, kidney units generally prefer a call they can reassure you about to a silence they later regret. Every decision about treatment, timing and medicines sits with your treating team; your role is to notice changes and report them early.
Frequently asked questions
What stage of kidney disease requires dialysis?
Dialysis is normally considered at stage 5, when eGFR is below 15 and the kidneys have lost roughly 85 to 90 percent of their function. Most people start because symptoms such as fluid overload, nausea, confusion or high potassium can no longer be controlled with medicines and diet. Stage 4 is the planning stage, when access surgery and transplant evaluation are arranged. Timing is decided individually by the kidney team.
When is dialysis needed based on eGFR alone?
Rarely on eGFR alone. Guidelines treat an eGFR below 15 as kidney failure, but the decision to start depends on symptoms and blood chemistry, not just the number. Someone with an eGFR of 12 who eats well and has normal potassium may be monitored, while someone at 16 with fluid in the lungs may start sooner. Repeat testing is used because single eGFR values can be affected by dehydration, diet and muscle mass.
Is a kidney transplant better than dialysis?
For medically suitable people, guideline bodies describe transplant as the option that most closely restores normal kidney function and offers more freedom than dialysis. It involves surgery, lifelong immunosuppressant medicines and risks of rejection and infection. Not everyone qualifies, and waiting times for a deceased-donor kidney are often years. Whether transplant or dialysis is better for a specific person is a decision for the transplant and nephrology teams.
Can I have a transplant without ever starting dialysis?
Yes. This is called a preemptive transplant and is often preferred when a living donor is available. It requires completing the evaluation during stage 4, typically once eGFR falls below about 20, so the operation can be scheduled before kidney failure causes symptoms. People already on dialysis remain eligible for transplant; starting treatment does not remove anyone from consideration.
What should I expect at stage 4 kidney disease?
Expect appointments to shift toward preparation. Typical steps include education sessions on dialysis, transplant and conservative management, dietitian review, anemia and bone treatment, vaccination checks, advice to protect one arm’s veins, and transplant referral if suitable. Blood tests move to every one to three months. Many people feel reasonably well at stage 4, which is normal and is exactly why planning happens now.
Does starting dialysis earlier help people live longer?
The best evidence says no. The IDEAL trial randomized over 800 adults to start dialysis at an eGFR of 10 to 14 or to wait for symptoms or a lower level, and found no difference in survival or major complications. Starting earlier mainly adds treatment burden. Planning early, by arranging access and transplant evaluation, is valuable; starting early without symptoms is not.
How long does a fistula take before it can be used?
An arteriovenous fistula typically needs about two to three months to mature after surgery, according to NIDDK, and some take longer or fail and need revision. A synthetic graft can usually be used within weeks but carries higher clotting and infection risk. If dialysis is needed before access is ready, a temporary neck or chest catheter is used as a bridge.
Can dialysis be stopped if my kidneys recover?
In chronic kidney disease, recovery is uncommon because the damage is long-standing, so dialysis is usually ongoing until transplant. In acute kidney injury, a sudden drop in function from illness, surgery or medicines, dialysis is often temporary and stopped once the kidneys heal. Some people also choose to stop dialysis for quality-of-life reasons; that decision is made with the kidney team and often with palliative care support.
What is conservative kidney management?
It is a planned approach to kidney failure that controls symptoms and complications with medicines, diet and close follow-up, without dialysis. It is commonly chosen by people who are frail or have other serious illnesses, where dialysis may add burden without extending life meaningfully. It includes treatment for fluid, potassium, anemia, itching and breathlessness, plus advance care planning. The NHS lists it as a formal option alongside dialysis and transplant.
Will I still need to limit fluids and diet on dialysis?
Usually yes. Dialysis runs only part of the time, so fluid, salt, potassium and phosphate can build up between sessions. A dietitian sets individual targets based on remaining urine output and blood results. People on peritoneal dialysis or with residual kidney function often have more flexibility. Limits are reviewed regularly and change over time rather than being fixed.
References
- NHS: Chronic kidney disease, Treatment
- NHS: Dialysis
- NIH NIDDK: Choosing a Treatment for Kidney Failure
- NIH NIDDK: Hemodialysis
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
More from the Blog
What to Expect After Varicocele Repair: How Semen Parameters Are Rechecked Over Months
After varicocele repair, semen is usually rechecked with a laboratory semen analysis around three months later, because sperm take roughly two to three months…
Infection, Stricture or Injury: How Urethra Diseases Are Told Apart and Treated
Urethra diseases fall into three broad groups: infection (urethritis), narrowing from scar tissue (stricture) and physical injury. Clinicians separate them by history, a urine…
The Post-Vasectomy Semen Analysis: How the Sample Is Checked and What the Report Shows
A post-vasectomy semen analysis is a laboratory check of an ejaculated sample, usually done about 8 to 16 weeks after the procedure, to confirm…
What Follow-Up Comes After Prostate HIFU Focal Therapy? PSA Checks, Imaging and Repeat Review
Follow-up after prostate HIFU focal therapy usually combines regular PSA blood tests, periodic MRI scans of the prostate, and in many programs a planned…
After Torsion Surgery: What to Expect for the Testicle, Fertility and Long-Term Follow-Up
After surgery for testicular torsion, most people go home the same day or the next, return to school or desk work within about a…
Which Tests Shape an Enlarged Prostate Plan? Uroflowmetry, PSA and Residual Urine Explained
An enlarged prostate plan is usually shaped by three measurements working together: uroflowmetry, which records how fast urine leaves the body; a post-void residual…






